Zhidong Lv
Qingdao, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
FTO promotes cancer progression by regulating VGLL4 m6A levels to activate STAT3 signaling in triple-negative breast cancer.
Journal: The Journal of biological chemistry
Published: January 26, 2026
Predicting Pathological Complete Response in Breast Cancer After Two Cycles of Neoadjuvant Chemotherapy by Tumor Reduction Rate: A Retrospective Case-Control Study.
Journal: Journal of breast cancer
Published: July 20, 2022
Impact of hormone receptor, HER2, and Ki-67 status conversions on survival after neoadjuvant chemotherapy in breast cancer patients: a retrospective study.
Journal: Annals of translational medicine
Published: December 01, 2021
Targeting PGC1α to wrestle cancer: a compelling therapeutic opportunity.
Journal: Journal of cancer research and clinical oncology
Published: November 18, 2021
OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer.
Journal: International immunopharmacology
Published: July 28, 2021
Quantification of Ki67 Change as a Valid Prognostic Indicator of Luminal B Type Breast Cancer After Neoadjuvant Therapy.
Journal: Pathology oncology research : POR
Published: July 20, 2021
Tumor-associated macrophages-mediated CXCL8 infiltration enhances breast cancer metastasis: Suppression by Danirixin.
Journal: International immunopharmacology
Published: May 31, 2020
MiR-204-5p Inhibits Transforming Growth Factor-β1-Induced Proliferation and Extracellular Matrix Production of Airway Smooth Muscle Cells by Regulating Six1 in Asthma.
Journal: International archives of allergy and immunology
Published: November 01, 2019
Long noncoding RNA LUCAT1 promotes breast cancer cell proliferation and invasion via promoting Mcl-1.
Journal: Panminerva medica
Published: October 03, 2019
p53-independent role of MYC mutant T58A in the proliferation and apoptosis of breast cancer cells.
Journal: Oncology letters
Published: February 28, 2018
PRRX1 drives tamoxifen therapy resistance through induction of epithelial-mesenchymal transition in MCF-7 breast cancer cells.
Journal: International journal of clinical and experimental pathology
Published: January 12, 2018
Luminal breast cancer classification according to proliferative indices: clinicopathological characteristics and short-term survival analysis.
Journal: Medical oncology (Northwood, London, England)
Published: April 08, 2014
Last Updated: 09/26/2026